Dual Roles of Tumour Cells-derived Matrix Metalloproteinase 2 on Brain Tumour Growth and Invasion

Overview

Journal Br J Cancer

Specialty Oncology

Date 2017 Oct 25

PMID 29065106

Citations 24

Authors

Ching-Fang Yu

Fang-Hsin Chen

Meng-Hsuan Lu

Ji-Hong Hong

Chi-Shiun Chiang

Affiliations

Soon will be listed here.

Abstract

Background: A previous study on a murine astrocytoma cell-line ALTS1C1 showed a highly invasive pattern similar to clinical anaplastic astrocytoma in vivo. This cell-line also expressed a high level of matrix metalloproteinase 2 (MMP2). This study aimed to verify the role of MMP2 in brain tumour progression.

Methods: ALTS1C1 and MMP2 knockdown (MMP2kd) cells were inoculated intracranially, and tumour microenvironment was assessed by immunohistochemistry staining.

Results: MMP2 expression was co-localised with CD31-positive cells at invading the tumour front and correlated with an invasive marker GLUT-1. The suppression of MMP2 expression prolonged the survival of tumour-bearing mice associated with tumours having smoother tumour margins, decreased Ki67-proliferating index, and down-regulated GLUT-1 antigen. Although the reduction of MMP2 expression did not alter the vessel density in comparison to parental ALTS1C1 tumours, vessels in MMP2kd tumours were less functional, as evidenced by the low ratio of pericyte coverage and reduction in Hoechst33342 dye perfusion.

Conclusions: This study illustrated that tumour-derived MMP2 has at least two roles in tumour malignancy; to enhance tumour invasiveness by degrading the extracellular matrix and to enhance tumour growth by promoting vessel maturation and function.

Citing Articles

Distinct roles of small extracellular vesicles from resident and infiltrating macrophages on glioma growth and mobility.

Chen C, Hsu S, Yu W, Chiang C, Yu C J Cancer. 2025; 16(3):969-981.

PMID: 39781357 PMC: 11705045. DOI: 10.7150/jca.103595.

The Complex Role of Matrix Metalloproteinase-2 (MMP-2) in Health and Disease.

Wolosowicz M, Prokopiuk S, Kaminski T Int J Mol Sci. 2025; 25(24.

PMID: 39769454 PMC: 11728377. DOI: 10.3390/ijms252413691.

Cysteamine Suppresses Cancer Cell Invasion and Migration in Glioblastoma through Inhibition of Matrix Metalloproteinase Activity.

Jung J, Celiku O, Rubin B, Gilbert M Cancers (Basel). 2024; 16(11).

PMID: 38893149 PMC: 11171184. DOI: 10.3390/cancers16112029.

Lineage specification in glioblastoma is regulated by METTL7B.

Constantinou M, Nicholson J, Zhang X, Maniati E, Lucchini S, Rosser G Cell Rep. 2024; 43(6):114309.

PMID: 38848215 PMC: 11220825. DOI: 10.1016/j.celrep.2024.114309.

Diagnostic and Therapeutic Approaches for Glioblastoma and Neuroblastoma Cancers Using Chlorotoxin Nanoparticles.

Boltman T, Meyer M, Ekpo O Cancers (Basel). 2023; 15(13).

PMID: 37444498 PMC: 10341066. DOI: 10.3390/cancers15133388.

References

Frankowski H, Gu Y, Heo J, Milner R, Del Zoppo G . Use of gel zymography to examine matrix metalloproteinase (gelatinase) expression in brain tissue or in primary glial cultures. Methods Mol Biol. 2011; 814:221-33. PMC: 3670093. DOI: 10.1007/978-1-61779-452-0_15. View

Younes M, Brown R, Mody D, Fernandez L, Laucirica R . GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res. 1995; 15(6B):2895-8. View

Komatsu K, Nakanishi Y, Nemoto N, Hori T, Sawada T, Kobayashi M . Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas. Brain Tumor Pathol. 2005; 21(3):105-12. DOI: 10.1007/BF02482184. View

Martin D, Ho A, Inderdeo D, Tsao M, Khokha R . Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. Lab Invest. 1999; 79(2):225-34. View

Forsyth P, Wong H, Laing T, Rewcastle N, Morris D, Muzik H . Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer. 1999; 79(11-12):1828-35. PMC: 2362801. DOI: 10.1038/sj.bjc.6690291. View

Blumenthal D, Gorlia T, Gilbert M, Kim M, Nabors L, Mason W . Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG. Neuro Oncol. 2017; 19(8):1119-1126. PMC: 5570239. DOI: 10.1093/neuonc/nox025. View

Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara R . The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 2001; 107(6):789-800. DOI: 10.1016/s0092-8674(01)00597-9. View

Rao J . Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer. 2003; 3(7):489-501. DOI: 10.1038/nrc1121. View

Vu T, Shipley J, Bergers G, Berger J, Helms J, Hanahan D . MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 1998; 93(3):411-22. PMC: 2839071. DOI: 10.1016/s0092-8674(00)81169-1. View

10.

Furudoi A, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G . Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma. Oncology. 2001; 60(2):162-9. DOI: 10.1159/000055314. View

11.

Kuwada Y, Sasaki T, Morinaka K, Kitadai Y, Mukaida N, Chayama K . Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells. Int J Oncol. 2003; 22(4):765-71. View

12.

Droppelmann C, Gutierrez J, Vial C, Brandan E . Matrix metalloproteinase-2-deficient fibroblasts exhibit an alteration in the fibrotic response to connective tissue growth factor/CCN2 because of an increase in the levels of endogenous fibronectin. J Biol Chem. 2009; 284(20):13551-13561. PMC: 2679456. DOI: 10.1074/jbc.M807352200. View

13.

Rosenberg G . Matrix metalloproteinases in brain injury. J Neurotrauma. 1995; 12(5):833-42. DOI: 10.1089/neu.1995.12.833. View

14.

Sawaya R, Yamamoto M, Gokaslan Z, Wang S, Mohanam S, Fuller G . Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis. 1996; 14(1):35-42. DOI: 10.1007/BF00157684. View

15.

McCawley L, Matrisian L . Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol. 2001; 13(5):534-40. DOI: 10.1016/s0955-0674(00)00248-9. View

16.

Bredin C, Liu Z, Klominek J . Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines. Anticancer Res. 2004; 23(6C):4877-84. View

17.

Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G . Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A. 2000; 97(8):3884-9. PMC: 18111. DOI: 10.1073/pnas.97.8.3884. View

18.

RAY J, Stetler-Stevenson W . The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J. 1994; 7(11):2062-72. View

19.

Guo P, Imanishi Y, Cackowski F, Jarzynka M, Tao H, Nishikawa R . Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma. Am J Pathol. 2005; 166(3):877-90. PMC: 1602359. DOI: 10.1016/s0002-9440(10)62308-5. View

20.

Wang S, Hong J, Hsueh C, Chiang C . Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model. Lab Invest. 2011; 92(1):151-62. DOI: 10.1038/labinvest.2011.128. View